Foundation Medicine (FMI)

136.40 -0.05 (0.04%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/31/18 *Est.)
- M&A (12/31/18 *Est)

Latest Headlines

Form 8-K Foundation Medicine, For: Jun 21 June 21, 2018 4:03 PM - SEC Filing Form SC14D9C Foundation Medicine, Filed by: Foundation Medicine, Inc. June 19, 2018 5:32 PM - SEC Filing Form SC14D9C Foundation Medicine, Filed by: Foundation Medicine, Inc. June 19, 2018 5:32 PM - SEC Filing Form SC14D9C Foundation Medicine, Filed by: Foundation Medicine, Inc. June 19, 2018 5:30 PM - SEC Filing Form 8-K Foundation Medicine, For: Jun 18 June 19, 2018 5:23 PM - SEC Filing Form 4 Foundation Medicine, For: Jun 15 Filed by: Pellini Michael J June 19, 2018 4:04 PM - SEC Filing William Blair Downgrades Foundation Medicine (FMI) to Market Perform Following Takeover June 19, 2018 12:48 PM - StreetInsider Pre-Open Movers 06/19: (ASTC) (FMI) (GEVO) Higher; (PAGS) (TELL) (DEA) Lower (more...) June 19, 2018 9:06 AM - StreetInsider Foundation Medicine (FMI) option implied volatility flat into Roche acquires for $2.4B June 19, 2018 6:32 AM - StreetInsider Form SC 13D/A Foundation Medicine, Filed by: ROCHE HOLDING LTD June 19, 2018 6:26 AM - SEC Filing Roche to Acquire Foundation Medicine (FMI) for $137/Share, or $5.3B June 19, 2018 6:18 AM - StreetInsider Roche pays $2.4 billion for rest of cancer expert Foundation Medicine June 19, 2018 1:38 AM - StreetInsider Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology June 19, 2018 1:01 AM - StreetInsider Form 8-K Foundation Medicine, For: Jun 06 June 7, 2018 4:03 PM - SEC Filing Foundation Medicine to Present at Upcoming Investor Conferences June 5, 2018 7:00 AM - BizWire Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care May 29, 2018 7:00 AM - BizWire Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK) May 24, 2018 7:05 AM - StreetInsider Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck May 24, 2018 7:00 AM - BizWire Form 4 Foundation Medicine, For: May 21 Filed by: Miller Vincent A. May 23, 2018 4:07 PM - SEC Filing Foundation Medicine (FMI) Secures New ADLT Status for FoundationOne CDx May 21, 2018 7:03 AM - StreetInsider Foundation Medicine Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services (CMS) May 21, 2018 7:00 AM - BizWire Form 4 Foundation Medicine, For: May 16 Filed by: Cox Troy May 17, 2018 4:14 PM - SEC Filing Form 4 Foundation Medicine, For: May 15 Filed by: Pellini Michael J May 17, 2018 4:13 PM - SEC Filing Form 4 Foundation Medicine, For: May 07 Filed by: Cox Troy May 9, 2018 4:06 PM - SEC Filing Form 10-Q Foundation Medicine, For: Mar 31 May 2, 2018 5:23 PM - SEC Filing Foundation Medicine (FMI) Tops Q1 EPS by 8c May 2, 2018 4:47 PM - StreetInsider Form 8-K Foundation Medicine, For: May 02 May 2, 2018 4:04 PM - SEC Filing Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights May 2, 2018 4:01 PM - BizWire Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer May 2, 2018 7:00 AM - BizWire Form DEFA14A Foundation Medicine, April 27, 2018 4:03 PM - SEC Filing Form DEF 14A Foundation Medicine, For: Jun 21 April 27, 2018 4:01 PM - SEC Filing Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China April 26, 2018 6:00 PM - BizWire Foundation Medicine (FMI) Says New Liquid Biopsy Assay Granted Breakthrough Device Designation April 26, 2018 7:25 AM - StreetInsider Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration April 26, 2018 7:00 AM - BizWire Form 4 Foundation Medicine, For: Apr 16 Filed by: Ryan Jason April 18, 2018 4:09 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 16 Filed by: Pellini Michael J April 18, 2018 4:08 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 16 Filed by: Miller Vincent A. April 18, 2018 4:08 PM - SEC Filing H3 Biomedicine, in Collaboration with Foundation Medicine (FMI), Announces Discovery of Recurrent RNA Splicing Factor Mutations in Non-Hodgkin’s Lymphoma and Multiple Myeloma April 17, 2018 9:10 AM - StreetInsider H3 Biomedicine Reports Discovery of Recurrent RNA Splicing Factor Mutations in Non-Hodgkin’s Lymphoma and Multiple Myeloma April 17, 2018 9:00 AM - BizWire Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call April 17, 2018 7:00 AM - BizWire Foundation Medicine (FMI), Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling April 11, 2018 7:03 AM - StreetInsider Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies April 11, 2018 7:00 AM - BizWire H3 Biomedicine to Present at 2018 American Association for Cancer Research Annual Meeting April 10, 2018 8:30 AM - BizWire Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care April 9, 2018 8:54 AM - PR NewsWire Form 4 Foundation Medicine, For: Apr 03 Filed by: Ryan Jason April 5, 2018 4:16 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 03 Filed by: Doherty Michael J April 5, 2018 4:16 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 03 Filed by: Pellini Michael J April 5, 2018 4:15 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Ryan Jason April 3, 2018 4:17 PM - SEC Filing Form 4/A Foundation Medicine, For: Mar 09 Filed by: Miller Vincent A. April 3, 2018 4:17 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Nallicheri Melanie April 3, 2018 4:17 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Hesslein Robert W. April 3, 2018 4:16 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Miller Vincent A. April 3, 2018 4:16 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Fiedler Konstantin April 3, 2018 4:14 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Cox Troy April 3, 2018 4:13 PM - SEC Filing Form 4 Foundation Medicine, For: Apr 01 Filed by: Doherty Michael J April 3, 2018 4:13 PM - SEC Filing Form CT ORDER Foundation Medicine, April 2, 2018 11:48 AM - SEC Filing Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagno March 30, 2018 7:00 AM - BizWire Full Article List